The Latest Breaking News from FDA

The pharmaceutical industry is undergoing rapid growth and expansion, driven by rising medical needs, favorable regulatory measures, and the implementation of pharma 4.0. Hence, investors could snatch up quality pharma stocks Bristol-Myers Squibb (BMY), Spero Therapeutics (SPRO), and OptiNose (OPTN) for steady returns during market dips. Read more.

The FDA has just approved the Apple Watch's AFib feature in a watershed moment for digital health tech.

Regulators in the US say the atrial fibrillation history feature can be used to assess other devices.

Pharma companies are slashing insulin production in favour of more lucrative weight-loss drugs.

With rising medicine demand and drug shortages in the U.S., pharmaceutical stocks under $20 present lucrative opportunities for investors, promising substantial returns in a ripe market. So, I think fundamentally solid pharma stocks ACADIA Pharmaceuticals (ACAD), Amneal Pharmaceuticals (AMRX), and OptiNose (OPTN), which are currently trading under $20, could be…

The Department of Medical Sciences has warned against overconsumption of kratom-mixed beverages, saying the drink may contain a higher level of mitragynine than the Food and Drug Administration's (FDA) recommendation.

FDA testing confirms safety of dairy products in the US market, offering reassurance to consumers amid bird flu concerns.

For some conditions, few approved treatments exist. Without accelerated approval, the FDA is failing patients

The outbreak linked to contaminated organic walnuts sold in bulk bins has led to 12 reported cases of illness and seven hospitalizations in California and Washington.

There are plenty of challenges to blood glucose monitoring, but rumors suggest it's a top priority for Apple.

Agency announces rule on methylene chloride, colorless liquid used for stripping paint, cleaning metal and decaffeinating coffee